1007 related articles for article (PubMed ID: 33169644)
1. Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.
Soto M; diZerega G; Rodgers KE
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972018. PubMed ID: 33169644
[TBL] [Abstract][Full Text] [Related]
2. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
3. Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.
Cure E; Cumhur Cure M; Vatansev H
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972015. PubMed ID: 33169637
[No Abstract] [Full Text] [Related]
4. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
Delpino MV; Quarleri J
Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
[No Abstract] [Full Text] [Related]
5. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
Hrenak J; Simko F
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
[TBL] [Abstract][Full Text] [Related]
6. ACE2 and COVID-19 and the resulting ARDS.
Zhang X; Li S; Niu S
Postgrad Med J; 2020 Jul; 96(1137):403-407. PubMed ID: 32522846
[TBL] [Abstract][Full Text] [Related]
7. COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.
Tan CS; Yeoh SF; Long CM
Ann Acad Med Singap; 2020 Jun; 49(6):398-400. PubMed ID: 32712639
[No Abstract] [Full Text] [Related]
8. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and the pulmonary vascular injury.
Dai HL; Guang XF
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972276. PubMed ID: 33176538
[No Abstract] [Full Text] [Related]
10. Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?
Peiró C; Moncada S
Circulation; 2020 May; 141(21):1665-1666. PubMed ID: 32242749
[No Abstract] [Full Text] [Related]
11. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
Cadegiani FA
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E587-E588. PubMed ID: 32297520
[No Abstract] [Full Text] [Related]
12. Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients.
Silva-Aguiar RP; Peruchetti DB; Rocco PRM; Schmaier AH; E Silva PMR; Martins MA; Carvalho VF; Pinheiro AAS; Caruso-Neves C
Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L596-L602. PubMed ID: 32783619
[TBL] [Abstract][Full Text] [Related]
13. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 - Does This Disease Kill Due to Imbalance of the Renin Angiotensin System (RAS) Caused by Genetic and Gender Differences in the Response to Viral ACE 2 Attack?
Arnold RH
Heart Lung Circ; 2020 Jul; 29(7):964-972. PubMed ID: 32564908
[TBL] [Abstract][Full Text] [Related]
15. Is there an impact of the COVID-19 pandemic on male fertility? The ACE2 connection.
Younis JS; Abassi Z; Skorecki K
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E878-E880. PubMed ID: 32421367
[TBL] [Abstract][Full Text] [Related]
16. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
Steckelings UM; Sumners C
Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
[TBL] [Abstract][Full Text] [Related]
17. Covid-19: the renin-angiotensin system imbalance hypothesis.
Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
Sommerstein R; Kochen MM; Messerli FH; Gräni C
J Am Heart Assoc; 2020 Apr; 9(7):e016509. PubMed ID: 32233753
[No Abstract] [Full Text] [Related]
19. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.
Turgeon RD; Zieroth S; Bewick D; Chow CM; Clarke B; Cowan S; Fordyce CB; Fournier A; Gin K; Gupta A; Hardiman S; Jackson S; Lau B; Leong-Poi H; Mansour S; Marelli A; Quraishi AR; Roifman I; Ruel M; Sapp J; Singh G; Small G; Virani S; Wood DA; Krahn A
Can J Cardiol; 2020 Aug; 36(8):1180-1182. PubMed ID: 32502522
[No Abstract] [Full Text] [Related]
20. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
Gemmati D; Tisato V
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]